PHS
XENT

PFM Health Sciences’s Intersect ENT, Inc XENT Stock Holding History

PFM Health Sciences’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-768,366
Closed -$23.9M – 106
2017
Q3 		$23.9M Buy
768,366
+374,028
+95% +$11.1M 0.47% 63
2017
Q2 		$11M Buy
394,338
+254,727
+182% +$5.77M 0.3% 74
2017
Q1 		$2.39M Buy
+139,611
New +$1.96M 0.06% 96
2016
Q2 		– Sell
-57,089
Closed -$1.08M – 108
2016
Q1 		$1.08M Buy
+57,089
New +$1.03M 0.03% 81

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PFM Health Sciences's XENT Position: Q4 2017 in Review

PFM Health Sciences sold out of Intersect ENT, Inc (XENT) in Q4 2017, closing a stake of 768,366 shares — an estimated $23.9M sold.

PFM Health Sciences first reported a position in XENT in Q1 2016 and held it in 4 quarters. The position peaked at $23.9M in Q3 2017. 157 funds tracked by Wall St. Rank hold XENT as of Q4 2017.

  • PFM Health Sciences reported no remaining Intersect ENT, Inc position as of Q4 2017 after selling out during the quarter.
  • PFM Health Sciences sold 768,366 Intersect ENT, Inc shares in Q4 2017, an estimated $23.9M.
  • PFM Health Sciences first reported a position in Intersect ENT, Inc in Q1 2016 and held it in 4 quarters.
  • PFM Health Sciences's Intersect ENT, Inc position peaked at $23.9M in Q3 2017.
  • 157 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2017.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.